Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Final Coverage-With-Evidence-Development Guidance Delayed By CMS Staff Cuts

Nov 08 2013

Related Content

CMS Redefines Coverage-With-Evidence-Development In Draft Guidance

Dec 03 2012

CMS Ambiguous On Role Of Local Contractors In Coverage With Evidence Development

Dec 10 2012

Reimbursement Briefs: Shutdown Might Delay CMS Regs; TEC Assessments; PCORI News

Oct 28 2013

CMS Proposes Noncoverage For Percutaneous Image-guided Lumbar Decompression

Oct 21 2013

Industry Pushes CMS For Details On Centralized Coverage Review Of IDE Trials

Sep 16 2013

CDRH Sequestration Impact: Training, Standards And Reg Science

Apr 22 2013

Sequestration Takes Hold: Full FDA Impact Remains To Be Seen

Mar 04 2013

Device Makers Seek Clarity On CMS' Plans For Coverage With Evidence Development

Feb 18 2013

CMS Proposes Centralized Review, New Standards For Reimbursement Of IDE Studies

Jul 09 2013

NIH Sequester: Grants Down, But SBIR Program Less Impacted

Jun 10 2013

Additional Topics

Reimbursement Medical Device

More from Policy & Regulation

More from Medtech Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window